Chiec, Lauren
Kumthekar, Priya
Article History
Accepted: 21 December 2021
First Online: 25 January 2022
Declarations
:
: No external funding was used in the preparation of this article.
: PK has received research and grant support from Genentech, Novocure, DNAtrix, and Orbus Therapeutics. PK has served on medical advisory boards for Biocept, Sintetica, Novocure, Janssen, Affinia, Celularity, and SDP Oncology. PK has provided consulting to Bliss Bio, Biocept, Enclear Therapies, Angiochem, and Affinia Therapeutics. LC has no conflicts of interest relevant to this article.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Dr. LC and Dr. PK both contributed to synthesis of the literature and drafting of the manuscript.